Comparative bioavailability of two acebutolol formulations
Verbesselt, R.; Tjandramaga, T.B.; Mullie, A.; De Schepper, P.J.
Bollettino Chimico Farmaceutico 117(2): 102-106
1978
ISSN/ISBN: 0006-6648 PMID: 743358 Document Number: 126731
Document emailed within 1 workday
Related Documents
Trejo, D.; Toledo, A.; Carrasco-Portugal, M.d.C.; Aguilar-Cota, M.ía.E.; Herrera, J.E.; Flores-Murrieta, F.J. 2003: Comparative bioavailability of two oral formulations of ciprofloxacin Proceedings of the Western Pharmacology Society 46: 134-135Riaz, H.; Goodman, B.; Bashir, S.; Hussain, S.; Mahmood, S.; Malik, F.; Waseem, D.; Raza, S.A.; Mahmood, W.; Alamgeer 2016: Comparative Bioavailability Analysis of Oral Alendronate Sodium Formulations in Pakistan Acta Poloniae Pharmaceutica 73(4): 999-1007
Mendes, G.B.; Franco, L.M.; Moreno, R.A.; Fernandes, A.G.; Muscara, M.N.; de Nucci, G. 1994: Comparative bioavailability of two suspension formulations of potassium diclofenac in healthy male volunteers International Journal of Clinical Pharmacology and Therapeutics 32(3): 131-135
Di Nola, F.; Soranzo, M.L. 1983: Comparative study, on healthy volunteers, of the bioavailability of 2 pharmaceutical formulations of oral cofosfolactamines. Trials between subjects Minerva Medica 74(6): 239-248
Hasan, M.M.; Najib, N.M.; Muti, H. 1993: A comparative bioavailability study on two sustained-release formulations of diclofenac sodium following a single dose administration International Journal of Clinical Pharmacology Therapy and Toxicology 31(8): 387-391
Seth, B.L. 1992: Comparative pharmacokinetics and bioavailability study of percutaneous absorption of diclofenac from two topical formulations containing drug as a solution gel or as an emulsion gel Arzneimittel-Forschung 42(2): 120-122
Schmidt, P.C.; Kaupp, H. 1993: Stability and new formulations of hexetidine. 2. Formulations and in vitro bioavailability Die Pharmazie 48(11): 837-841
Jutasompakorn, P.; Kongpatanakul, S.; Pongnarin, P.; Sathirakul, K.; Chatsiricharoenkul, S. 2015: Comparative Fasting Bioavailability of 2 Cilostazol Formulations in Healthy Thai Volunteers: An Open-Label, Single-Dose, Randomized, 2-Way Crossover Study Journal of the Medical Association of Thailand 98(9): 910-915
Markiewicz, A.; Semenowicz, K.; Szczyrba, E.; Kocek, B. 1978: Comparison of bioavailability of two dipyridamole formulations Polish Journal of Pharmacology and Pharmacy 30(5): 605-609
Cano, J.P.; Soliva, M.; Hartmann, D.; Ziegler, W.H.; Amrein, R. 1977: Bioavailability from various galenic formulations of flunitrazepam Arzneimittel-Forschung 27(12): 2383-2388
Franke, G.; Diletti, E.; Hoffmann, C.; Zschiesche, M.; Scheuch, E.; Siegmund, W. 1995: Relative bioavailability of different valproic acid formulations International Journal of Clinical Pharmacology and Therapeutics 33(12): 653-657
González-Peñas, E.; Echeverría, H.C.; Mosquera, J.; Esteras, A.; Bruseghini, L. 2003: Bioavailability of two dermal formulations of S(+)ibuprofen in rabbit Arzneimittel-Forschung 53(11): 786-792
Bousquet, E.; Tirendi, S.; Bonina, F.P.; Montenegro, L.; Bianchi, A.; Ciampini, N. 1992: Bioavailability of two formulations of acetylsalicylic acid gums Die Pharmazie 47(8): 607-609
Gafiţanu, E.; Dumistrăcel, I.; Antochi, S. 1991: Formulations and bioavailability of propyphenazone in lyophilized tablets Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 95(1-2): 127-128
Lintz, W.; Barth, H.; Osterloh, G.; Schmidt-Böthelt, E. 1986: Bioavailability of enteral tramadol formulations. 1st communication: capsules Arzneimittel-Forschung 36(8): 1278-1283
Hespe, W.; Verschoor, J.S.; Olthoff, M. 1987: Bioavailability of new formulations of amoxicillin in relation to its absorption kinetics Arzneimittel-Forschung 37(3): 372-375
Chopra, R.K.; Goldman, R.; Sinatra, S.T.; Bhagavan, H.N. 1998: Relative bioavailability of coenzyme Q10 formulations in human subjects International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 68(2): 109-113
Ba, B.B.; Iliadis, A.; Durand, A.; Berger, Y.; Cano, J.P. 1988: New approach in bioavailability study of two formulations of ethyl loflazepate Arzneimittel-Forschung 38(10): 1486-1489
De Caro, G.; Maggi, L. 1984: Bioavailability in man of oral formulations of flunarizine (drops and capsules) Bollettino Chimico Farmaceutico 123(10): 65S-70S
Lapka, R.; Cepeláková, H.; Rejholec, V.; Franc, Z. 1986: Bioavailability of two oral formulations of triazolam using radioreceptor assay Die Pharmazie 41(4): 256-257